Externally-applied medicine for treating herpes zoster
What is Al technical title?
Al technical title is built by PatSnap Al team. It summarizes the technical point description of the patent document.
A technology of herpes zoster and external application, which is applied in the field of external application for the treatment of herpes zoster, which can solve the problems of long treatment time, adverse reactions, blood picture changes, etc., and achieve the effect of short treatment time, no toxic side effects, and scientific components
Inactive Publication Date: 2015-12-23
吴淑芬
View PDF2 Cites 3 Cited by
Summary
Abstract
Description
Claims
Application Information
AI Technical Summary
This helps you quickly interpret patents by identifying the three key elements:
Problems solved by technology
Method used
Benefits of technology
Problems solved by technology
Because it contains the active ingredient aciclovir, it will produce the following adverse reactions in varying degrees. First, skin and mucous membrane irritation symptoms, local skin erythema, dryness, itching, stinging, burning sensation, etc., can disappear after reducing the dose or stopping the drug Second, contact dermatitis, local skin rashes such as redness and swelling, maculopapules, blisters, erosions, etc....
Method used
the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more
Examples
Experimental program
Comparison scheme
Effect test
Embodiment 1
[0032] First, weigh each component: 2 parts of pearl, 15 parts of bezoar, 15 parts of realgar, 3 parts of borneol, 15 parts of toad venom, 15 parts of musk, 5 parts of panax notoginseng, 5 parts of cinnabar, and 25 parts of rice vinegar.
[0033] Preparation of ointment: First, grind pearl, bezoar, realgar, borneol, toad venom, musk, and cinnabar into fine powder, and then use rice vinegar to make a paste ointment.
[0034] Treatment method: Apply the ointment to the herpes, to the extent that it can cover the herpes and skin lesions. If there is ulceration and running water, the powder can be directly sprinkled on the affected area, 3 times a day, for a week.
Embodiment 2
[0036] First, weigh each component: 3 parts of pearl, 13 parts of bezoar, 13 parts of realgar, 4 parts of borneol, 13 parts of toad venom, 13 parts of musk, 7 parts of panax notoginseng, 7 parts of cinnabar, and 27 parts of rice vinegar.
[0037] Preparation ointment: same as embodiment 1.
[0038] Therapeutic method: same as embodiment 1.
Embodiment 3
[0040] First, weigh each component: 5 parts of pearl, 10 parts of bezoar, 10 parts of realgar, 5 parts of borneol, 10 parts of toad venom, 10 parts of musk, 10 parts of Panax notoginseng, 10 parts of cinnabar, and 30 parts of rice vinegar.
[0041] Preparation ointment: same as embodiment 1.
[0042] Therapeutic method: same as embodiment 1.
the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more
PUM
Login to view more
Abstract
The invention discloses externally-applied medicine for treating herpes zoster. The externally-applied medicine is prepared from, by weight, 2-8 parts of pearls, 5-15 parts of calculus bovis, 5-15 parts of realgar, 2-8 parts of borneol, 5-15 parts of arenobufagin, 5-15 parts of musk, 5-15 parts of panax notoginseng, 5-15 parts of cinnabar and 25-35 parts of rice vinegar. According to the externally-applied medicine, raw materials are scientifically and reasonably matched and support one another, and through combination of the raw medical materials, the effects of clearing away heat and toxic materials and activating blood to promote menstruation and relieve pain are realized, treatment time is short, and the medicine becomes effective fast and is free of toxic and side effects. The medicine is especially suitable for treating herpes zoster.
Description
technical field [0001] The invention relates to the technical field of medicines, in particular to a medicine for external application for treating herpes zoster. Background technique [0002] Herpes zoster is an acute infectious skin disease caused by the varicella-zoster virus. Chickenpox occurs when children who are not immune to the virus become infected. After being infected, some patients become carriers without symptoms. Due to the neurotropic nature of the virus, it can remain dormant in the neurons of the dorsal root ganglia of the spinal cord for a long time after infection. When the resistance is low or when you are tired, infected, or caught a cold, the virus can grow and multiply again, and move to the skin along the nerve fibers. Intense inflammation of affected nerves and skin. The rash is generally unilateral and distributed according to nerve segments, and consists of clustered herpes, accompanied by pain; the older you are, the more severe the neuralgia....
Claims
the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more
Application Information
Patent Timeline
Application Date:The date an application was filed.
Publication Date:The date a patent or application was officially published.
First Publication Date:The earliest publication date of a patent with the same application number.
Issue Date:Publication date of the patent grant document.
PCT Entry Date:The Entry date of PCT National Phase.
Estimated Expiry Date:The statutory expiry date of a patent right according to the Patent Law, and it is the longest term of protection that the patent right can achieve without the termination of the patent right due to other reasons(Term extension factor has been taken into account ).
Invalid Date:Actual expiry date is based on effective date or publication date of legal transaction data of invalid patent.
Login to view more 
Login to view more